Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cobalt is a transition metal and an essential trace element primarily known for its role as the central component of Vitamin B12 (cobalamin) [8, 12]. In this capacity, it serves as a vital cofactor for enzymes such as methionine synthase and methylmalonyl-CoA mutase, which are essential for DNA synthesis, neurological function, and energy metabolism [18]. Cobalt ions are also pharmacologically significant as hypoxia mimetics; they stabilize hypoxia-inducible factor 1-alpha (HIF-1α) by inhibiting its degradation, thereby stimulating the production of erythropoietin and red blood cells [7, 10]. Additionally, the radioisotope cobalt-60 is widely utilized in medical physics for external beam radiotherapy to treat various cancers through gamma radiation-induced DNA damage [16]. Cobalt complexes, such as Doxovir, have also been investigated for their potential as antiviral and antibacterial agents by targeting viral proteins [1, 6]. Despite its essentiality, excessive accumulation of cobalt can lead to severe health issues, including 'cobalt lung' (interstitial lung disease), cardiomyopathy, and polycythemia [19, 20]. These toxic effects are often associated with occupational exposure or wear from metal-on-metal joint prostheses [15, 19]. Management of cobalt toxicity typically involves the use of chelating agents to facilitate its excretion from the body [19].
Cobalt serves as a central cofactor in Vitamin B12, enabling enzymatic reactions in DNA synthesis and fatty acid metabolism [8, 12]. As a hypoxia mimetic, cobalt ions inhibit prolyl hydroxylases, leading to the stabilization of HIF-1α and subsequent induction of erythropoietin [7, 10]. In radiotherapy, the isotope Cobalt-60 provides high-energy gamma radiation to destroy cancer cells [13, 16]. Chelating agents like edetate calcium disodium interact with cobalt to treat systemic toxicity by forming stable, excretable complexes [19].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cobalt (Co).